Personal Genomic Tests: Innovation, Risk & Patient Empowerement

Genomics|Update|Current

Personal Genomic Tests: Innovation, Risk & Patient Empowerement

Innovation, risk, and patient empowerment, the FDA-mandated withdrawal of 23andMe’s personal genome service
N Downing et al. JAMA, January 27, 2014

How FDA and 23andMe dance around evidence that is not there, Cecile Janssens, Huffington post blog, Jan 27

CDC blog post: Think (again) before you spit-do personal genomic tests improve health?(2011)

CDC blog post: Think after you spit-Personal genomics and the teachable moment (2012)